This HTML5 document contains 185 embedded RDF statements represented using HTML+Microdata notation.

The embedded RDF content will be recognized by any processor of HTML5 Microdata.

Namespace Prefixes

PrefixIRI
n11http://linked.opendata.cz/resource/sukl/roa/
n2http://linked.opendata.cz/resource/sukl/medicinal-product-packaging/
dctermshttp://purl.org/dc/terms/
n10http://linked.opendata.cz/resource/sukl/medicinal-product-packaging/0027429/price/
n3http://linked.opendata.cz/ontology/sukl/
n14http://linked.opendata.cz/resource/sukl/specialization-restriction/
skoshttp://www.w3.org/2004/02/skos/core#
n20http://linked.opendata.cz/resource/sukl/indgroup/
n17http://linked.opendata.cz/resource/sukl/packing/
n19http://linked.opendata.cz/resource/sukl/company/
n13http://linked.opendata.cz/resource/sukl/active-ingredient/
rdfhttp://www.w3.org/1999/02/22-rdf-syntax-ns#
n9http://linked.opendata.cz/resource/sukl/medicinal-product-packaging/0027429/price-of-originator/
n7http://linked.opendata.cz/resource/sukl/registration-state/
n6http://linked.opendata.cz/resource/sukl/medicinal-product-packaging/0027429/reimbursement/
xsdhhttp://www.w3.org/2001/XMLSchema#
n16http://www.emea.europa.eu/docs/cs_CZ/document_library/EPAR_-_Product_Information/human/000379/
n15http://linked.opendata.cz/resource/sukl/medicinal-product-packaging/0027429/core-reimbursement/
n5http://linked.opendata.cz/resource/sukl/medicinal-product-packaging/0027429/
n8http://linked.opendata.cz/resource/sukl/df/
n4http://linked.opendata.cz/resource/atc/

Statements

Subject Item
n2:0027429
rdf:type
n3:MedicinalProductPackaging
dcterms:title
CANCIDAS 50 MG
skos:notation
0027429
n3:hasATCCode
n4:J02AX04
n3:hasActiveIngredient
n13:CASPOFUNGINI-DIACETAS
n3:hasDefinedDailyDose
n5:ddd
n3:hasDosageForm
n8:INF-PLV-CSL-IVN
n3:hasPackagingSize
1
n3:hasPacking
n17:VIA
n3:hasRegistrationHolder
n19:MSDGB
n3:hasRegistrationState
n7:R
n3:hasRouteOfAdministration
n11:IVN
n3:hasStrength
50MG
n3:hasIndicationGroup
n20:26
n3:hasSpecializationRestriction
n14:ATB
n3:containsDefinedDailyDoses
1.0
n3:hasRegistrationCode
EU/1/01/196/001
n3:hasTitleSupplement
INF PLV CSL 1X50MG
n3:containsUsualTherapeuticalDailyDoses
1
n3:hasCoreReimbursementSpecification
n15:2015-06-01 n15:2015-07-01 n15:2015-04-02 n15:2015-05-01 n15:2015-03-01 n15:2015-04-01 n15:2015-01-13 n15:2015-02-01 n15:2014-12-01 n15:2015-01-01 n15:2014-11-01 n15:2014-11-19 n15:2014-10-01 n15:2014-10-02 n15:2014-08-01 n15:2014-09-01 n15:2015-07-02 n15:2013-05-01 n15:2013-06-01 n15:2013-03-01 n15:2013-04-01 n15:2013-01-05 n15:2013-02-01 n15:2013-01-01 n15:2014-07-01 n15:2014-07-03 n15:2014-06-01 n15:2014-06-13 n15:2014-04-01 n15:2014-05-01 n15:2014-02-01 n15:2014-03-01 n15:2013-12-01 n15:2014-01-01 n15:2013-10-01 n15:2013-11-01 n15:2013-08-03 n15:2013-09-01 n15:2013-07-01 n15:2013-08-01
n3:hasPriceOfOriginatorSpecification
n9:2015-03-01 n9:2015-04-01 n9:2015-01-13 n9:2015-02-01 n9:2015-06-01 n9:2015-07-01 n9:2015-04-02 n9:2015-05-01 n9:2015-07-02 n9:2014-04-01 n9:2014-05-01 n9:2014-02-01 n9:2014-03-01 n9:2014-07-01 n9:2014-07-03 n9:2014-06-01 n9:2014-06-13 n9:2014-10-01 n9:2014-10-02 n9:2014-08-01 n9:2014-09-01 n9:2014-12-01 n9:2015-01-01 n9:2014-11-01 n9:2014-11-19 n9:2013-01-05 n9:2013-02-01 n9:2013-01-01 n9:2013-05-01 n9:2013-06-01 n9:2013-03-01 n9:2013-04-01 n9:2013-08-03 n9:2013-09-01 n9:2013-07-01 n9:2013-08-01 n9:2013-12-01 n9:2014-01-01 n9:2013-10-01 n9:2013-11-01
n3:hasPriceSpecification
n10:2013-03-01 n10:2013-04-01 n10:2013-05-01 n10:2013-06-01 n10:2013-01-01 n10:2013-01-05 n10:2013-02-01 n10:2015-07-02 n10:2014-11-01 n10:2014-11-19 n10:2014-12-01 n10:2015-01-01 n10:2014-08-01 n10:2014-09-01 n10:2014-10-01 n10:2014-10-02 n10:2015-04-02 n10:2015-05-01 n10:2015-06-01 n10:2015-07-01 n10:2015-01-13 n10:2015-02-01 n10:2015-03-01 n10:2015-04-01 n10:2013-10-01 n10:2013-11-01 n10:2013-12-01 n10:2014-01-01 n10:2013-07-01 n10:2013-08-01 n10:2013-08-03 n10:2013-09-01 n10:2014-06-01 n10:2014-06-13 n10:2014-07-01 n10:2014-07-03 n10:2014-02-01 n10:2014-03-01 n10:2014-04-01 n10:2014-05-01
n3:hasReimbursementSpecification
n6:2015-06-01 n6:2015-07-01 n6:2015-04-02 n6:2015-05-01 n6:2015-03-01 n6:2015-04-01 n6:2015-01-13 n6:2015-02-01 n6:2015-07-02 n6:2014-07-01 n6:2014-07-03 n6:2014-06-01 n6:2014-06-13 n6:2014-04-01 n6:2014-05-01 n6:2014-02-01 n6:2014-03-01 n6:2014-12-01 n6:2015-01-01 n6:2014-11-01 n6:2014-11-19 n6:2014-10-01 n6:2014-10-02 n6:2014-08-01 n6:2014-09-01 n6:2013-05-01 n6:2013-06-01 n6:2013-03-01 n6:2013-04-01 n6:2013-01-05 n6:2013-02-01 n6:2013-01-01 n6:2013-12-01 n6:2014-01-01 n6:2013-10-01 n6:2013-11-01 n6:2013-08-03 n6:2013-09-01 n6:2013-07-01 n6:2013-08-01
n3:hasResumedMarketingDate
2002-11-01+01:00
n3:hasUsualTherapeuticalDailyDose
n5:utdd
n3:pilFile
http%3A%2F%2Fwww.emea.europa.eu%2Fdocs%2Fcs_CZ%2Fdocument_library%2FEPAR_-_Product_Information%2Fhuman%2F000379%2FWC500021033.pdf
n3:pilUri
n16:WC500021033.pdf
n3:spcFile
http%3A%2F%2Fwww.emea.europa.eu%2Fdocs%2Fcs_CZ%2Fdocument_library%2FEPAR_-_Product_Information%2Fhuman%2F000379%2FWC500021033.pdf
n3:spcUri
n16:WC500021033.pdf